Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Growth - Direct Plan

Other Plans and Options
  • (-0.14%)Nav, as on 10-07-2025

  • Previous Nav

  • Net Change on 10-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to adopt passive investment strategy. The fund will invest in stocks comprising in the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
MSCI India Domestic & World Healthcare 45 Index N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Motilal Oswal Nifty 500 Index Fund - Direct Plan Sep 06, 2019 2.94 19.93 22.24 0.17 2,467.95
Motilal Oswal Nifty Midcap 150 Index Fund - Direct Plan Sep 06, 2019 2.95 28.11 30.64 0.26 2,459.71
Motilal Oswal Nifty Smallcap 250 Index Fund- Direct Plan Sep 06, 2019 1.22 28.85 33.04 0.33 978.30
Motilal Oswal Nifty Bank Index Fund - Direct Plan Sep 06, 2019 9.72 18.11 20.84 0.26 663.25

Fund Holdings as on 30-June-2025

  • Sun Pharmaceutical Industries Ltd.

  • Max Healthcare Institute Ltd.

  • Cipla Ltd.

  • Divi's Laboratories Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • ELI LILLY & CO

  • Apollo Hospitals Enterprise Ltd.

  • Lupin Ltd.

  • JOHNSON & JOHNSON

  • Torrent Pharmaceuticals Ltd.

  • ABBVIE INC

  • Fortis Healthcare Ltd.

  • Aurobindo Pharma Ltd.

  • Mankind Pharma Ltd.

  • ABBOTT LABORATORIES

  • NOVARTIS AG

  • Novo Nordisk A/S

  • Laurus Labs Ltd.

  • Zydus Lifesciences Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • MERCK & CO.INC

  • INTUITIVE SURGICAL INC

  • Alkem Laboratories Ltd.

  • IPCA Laboratories Ltd.

  • Biocon Ltd.

  • THERMO FISHER SCIENTIFIC INC

  • AMGEN INC

  • STRYKER CORP

  • GILEAD SCIENCES INC

  • Narayana Hrudayalaya ltd.

  • DANAHER CORP

  • GlaxoSmithKline Pharmaceuticals Ltd.

  • Gland Pharma Ltd.

  • VERTEX PHARMACEUTICALS INC

  • MEDTRONIC PLC

  • Piramal Pharma Ltd.

  • Syngene International Ltd.

  • Ajanta Pharma Ltd.

  • Cohance Lifesciences Ltd.

  • Global Health Ltd.

  • Regeneron Pharmaceuticals Inc

  • BECTON DICKINSON AND CO

  • AGILENT TECHNOLOGIES INC

  • IQVIA HOLDINGS INC

  • Clearing Corporation of India Ltd.

  • ILLUMINA INC

  • Net Receivables/(Payables)

  • Accrued Interest

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Business Support

View More

Fund Manager

  • Cash

  • Equity

View More

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Scheme Analysis

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is a Index Funds - Other fund and belongs to Edelweiss Mutual Fund. It was launched on 26-Oct-2020 and currently has an AUM of ₹161.38 crore. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is benchmarked against MSCI India Domestic & World Healthcare 45 Index as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund ended down ₹-0.03(-0.14%)yesterday to ₹20.1536.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is managed by Bhavesh Jain and Amit Vora.

Fund House Contact

Edelweiss House Off. C.S.T Road, Kalina, Mumbai - 400 098

(022) 40933400
(022) 40933401